Blog - Page 1458 of 5721

MondayMar 29, 2021 1:08 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Bringing Cost-Effective, Compact Solutions to Emergency Medicine

Brain Scientific (OTCQB: BRSF), with its low-cost, portable, wireless and easy-to-use electroencephalogram (“EEG”) devices, the NeuroCap(TM) and NeuroEEG(TM), has overcome the barriers preventing the use of EEGs in emergency settings. This means that patients and emergency departments can more readily realize numerous EEG benefits. An EEG can make the distinction between dementia and delirium, adequately determine the severity of a mild traumatic brain injury (“mTBI”), as well as identify nontraumatic causes of neurologic dysfunction such as syncope and vertigo. In contrast, head CTs or MRIs are not equipped to effectively perform any of these tasks, yet they are widely used.…

MondayMar 29, 2021 12:53 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Announces Pilot Launch of Consumer Auction Platform – DrivrzXchange

PowerBand Solutions (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a comprehensive e-commerce solution transforming the online experience to sell, trade, lease, and finance vehicles, today announced that DrivrzXchange, its online consumer auction platform, has begun a pilot launch in Northwest Arkansas, with plans to rapidly expand into select markets nationwide. According to the update, the consumer-to-consumer ("C2C") auction portal of DRIVRZ(TM), branded DrivrzXchange, is a marketplace that allows verified users to buy or sell vehicles online. "DrivrzXchange is superior to other live auctions, listing sites and car buying services because it offers anyone who is in the market to buy or…

MondayMar 29, 2021 12:37 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

GBM is diagnosed in more than 13,000 people each year in the US, with only a 12–18-month life expectancy Potentially pivotal Phase 2 trial of Berubicin is scheduled to commence around the end of Q1 2021 The company is continuing its pre-clinical work on WP1244 during 2021 and 2022 CNS Pharmaceuticals participated in two virtual conferences during March, spreading awareness about Berubicin and the GBM indicator CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system, recently announced multiple value-driving milestones for its lead drug candidate…

MondayMar 29, 2021 12:30 pm

QualityStocksNewsBreaks – Trident Acquisitions Corp.’s (NASDAQ: TDAC) Pending Business Combination Partner, Lottery.com, Enters Strategic Agreement, Featured in Exclusive Broadcast

Trident Acquisitions (NASDAQ: TDAC, TDACU, TDACW), a special purpose acquisition company, previously announced its entry into a definitive agreement with AutoLotto Inc., a leading online platform to play the lottery online. The agreement allows Lottery.com to become a publicly listed company. Today, Lottery.com announced its entry into an agreement with Payday Lotteries Limited, a federally licensed Nigeran lottery operator, to offer U.S. lottery products in Nigeria. The agreement will allow consumers in Nigeria to purchase select U.S. lottery products in the country, both physically and electronically, on the internet and through their mobile devices. “I’m truly excited to announce our…

MondayMar 29, 2021 12:17 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Commences Trade on the Frankfurt Stock Exchange

Pac Roots Cannabis recently revealed it had commenced trading on the Frankfurt Stock Exchange under symbol “4XM” German listing will add on to company’s existing listings on U.S. OTC market, Canadian Securities Exchange Pac Roots’ geographically diverse capital markets presence will allow it to cater to broader, more diverse investor audience Europe’s legal cannabis market expected to swell to market value of $37.1 billion by 2027 Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canada-based cannabis company dedicated towards producing premium-quality strains and products by leveraging a genetics-focused approach, announced that as of March 18, 2021, the company…

MondayMar 29, 2021 11:53 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Featured in NetworkNewsAudio Broadcast

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, this morning announced that it was featured in a NetworkNewsAudio production highlighting the company’s recent news that it has received European approval for its SARS-CoV-2 (COVID-19) RT-PCR test system (Covid-ID Lab). “Our test is one of the fastest PCR-based COVID-19 tests currently approved. With a sample collection to result time of 25 minutes, Covid-ID Lab combines the speed of a rapid screening test with the accuracy of a PCR diagnostic,” XPhyto CEO and Director Hugh Rogers…

MondayMar 29, 2021 11:52 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Orders First Functional Mushroom Shipment for Global E-Commerce Portal

PULL expands into EU through initial sale of cannabis oil extracts to German pharmaceutical company Sale to Germany expected to pave way for additional supply agreements throughout Europe Company orders first shipment of functional mushroom products for direct-to-consumer e-commerce portal, expects $15,000 gross monthly sales for each formulation PULL’s new state-of-the-art facility constructed to EU GMP standards for worldwide exports With a focus on the cannabis, hemp, functional mushrooms and rapidly emerging psychedelic sectors, Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a Canadian plant-based extraction company, is steadily increasing its market share through the achievement of several important…

MondayMar 29, 2021 11:25 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systems Helomics model evaluates multiple measurements in powerful multi-omics approach to cancer research Knowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to Mark Collins, PhD and chief technical officer at the company, which is a subsidiary of Predictive Oncology (NASDAQ: POAI) (https://ibn.fm/ms1hL). Collins was a guest speaker on a DojoLIVE! podcast titled “Can We Cure Cancer with Artificial Intelligence?” where…

MondayMar 29, 2021 11:09 am

QualityStocksNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Receives 5,000-Plus Sample Pack Requests in First Days of Campaign

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) launched a new ad campaign for its TAAT(TM) nicotine-free, tobacco-free cigarette alternative on Wednesday, March 24, 2021. In the first three days of the campaign, which was unveiled on TryTAAT, the company’s online e-commerce site, TAAT received more than 5,000 requests for its complimentary, sample pack of TAAT Original, Smooth or Menthol product. The requests came from users in all eligible states, and the company will begin fulfilling the requests this week. According to the announcement, TAAT plans to continue this campaign as it focuses on building brand awareness and recognition.…

MondayMar 29, 2021 10:39 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Secures $9.7M in Registered Direct Offering, Concurrent Private Placement

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, on Friday announced the closing of its previously announced registered direct offering of 2,190,000 of its shares of common stock priced at-the-market under Nasdaq rules. According to the update, Sigma Labs also issued to the investors short-term warrants to purchase up to an aggregate of 2,190,000 shares of common stock in a concurrent private placement. The combined purchase price for one common stock and a warrant to purchase one share of common stock was $4.445. Sigma Labs secured approximately $9.7 million in…

Site Search

Company Search